ArticleBlood advances2020

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.

Sung Choe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.